|Bid||0.00 x 3200|
|Ask||0.00 x 2900|
|Day's range||35.85 - 36.12|
|52-week range||31.60 - 41.14|
|Beta (5Y monthly)||0.73|
|PE ratio (TTM)||9.72|
|Forward dividend & yield||2.98 (8.31%)|
|Ex-dividend date||22 Dec 2021|
|1y target est||50.06|
Research firm Sustainalytics pitched its services to advisors and investors at the annual Morningstar Investment Conference (MIC).
Altria (MO) strives to expand IQOS and on! amid consumers' rising preference on low-risk tobacco alternatives. Moreover, strong pricing for tobacco products is driving revenues.
The FDA said the approval came after analysis of data from the manufacturer that showed that using Vuse's tobacco-flavored products could help users reduce exposure to harmful chemicals emitted by combustible cigarettes. "Today’s order represents an important moment for Reynolds," a British American Tobacco spokesperson said, referring to the company's American unit R.J. Reynolds Vapor Co, which had filed for Vuse's marketing approval. The FDA granted permission to R.J. Reynolds to market its Vuse Solo closed electronic nicotine-delivery device and two accompanying tobacco-flavored e-liquid pods, which have a nicotine strength of 4.8%, which is roughly equivalent to a pack of cigarettes.